Skip to main content

Peer Review reports

From: A real-world study comparing perioperative chemotherapy and EGFR-tyrosine kinase inhibitors for treatment of resected stage III EGFR-mutant adenocarcinoma

Original Submission
27 Apr 2023 Submitted Original manuscript
11 Jul 2023 Reviewed Reviewer Report - Kentaro Ito
25 Jul 2023 Author responded Author comments - Wen-Chien Cheng
27 Jul 2023 Author responded Author comments - Wen-Chien Cheng
Resubmission - Version 2
25 Jul 2023 Submitted Manuscript version 2
28 Jul 2023 Author responded Author comments - Wen-Chien Cheng
Resubmission - Version 3
28 Jul 2023 Submitted Manuscript version 3
Publishing
26 Aug 2023 Editorially accepted
11 Sep 2023 Article published 10.1186/s12885-023-11342-y

You can find further information about peer review here.

Back to article page